# Antiarrhythmics or Ablation for Ventricular Tachycardia 2

Study · id `cardio:ct-nct02830360` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02830360](<https://clinicaltrials.gov/study/NCT02830360>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02830360

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 416 participants.

## Technical summary

Registry record NCT02830360. Randomized; no masking; primary purpose treatment. Start 2016-10 (actual); primary completion 2024-06-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 416 participants (enrolled count; ClinicalTrials.gov record NCT02830360, source copy `cardio:ctgov-nct02830360-2024-08-01`, retrieved 2026-10-26)
- Started: 2016-10 (actual) (ClinicalTrials.gov record NCT02830360, source copy `cardio:ctgov-nct02830360-2024-08-01`, retrieved 2026-10-26)
- Primary completion: 2024-06-06 (actual) (ClinicalTrials.gov record NCT02830360, source copy `cardio:ctgov-nct02830360-2024-08-01`, retrieved 2026-10-26)
- Completion: 2024-06-30 (actual) (ClinicalTrials.gov record NCT02830360, source copy `cardio:ctgov-nct02830360-2024-08-01`, retrieved 2026-10-26)
- Countries: United States; Canada; France (ClinicalTrials.gov record NCT02830360, source copy `cardio:ctgov-nct02830360-2024-08-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02830360-2024-08-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Antiarrhythmics or Ablation for Ventricular Tachycardia 2
- Acronym: VANISH2
- Condition: Ventricular Tachycardia (VT)
- Intervention (Drug): Antiarrythmic Drug Therapy
- Intervention (Procedure): Catheter ablation
- Lead sponsor: John Sapp
- Lead sponsor class: OTHER
- Collaborator: Heart and Stroke Foundation of Canada
- Collaborator class: OTHER
- Collaborator: Abbott Medical Devices
- Collaborator class: INDUSTRY
- Collaborator: Biosense Webster, Inc.
- Collaborator class: INDUSTRY
- Collaborator: Ottawa Heart Institute Research Corporation
- Collaborator class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV
- Collaborator: Cardiac Arrhythmia Network of Canada
- Collaborator class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY
- Collaborator: Nova Scotia Health Authority
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as a collaborator: Heart and Stroke Foundation of Canada (`cardio:org-heart-and-stroke-foundation-of-canada`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)
- Registry lists this organization as a collaborator: Biosense Webster, Inc. (`cardio:org-biosense-webster-inc`)
- Registry lists this organization as a collaborator: Ottawa Heart Institute Research Corporation (`cardio:org-ottawa-heart-institute-research-corporation`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)
- Registry lists this organization as a collaborator: Cardiac Arrhythmia Network of Canada (`cardio:org-cardiac-arrhythmia-network-of-canada`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial (`cardio:pubmed-38649085`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia (`cardio:pubmed-39555820`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial (`cardio:pubmed-41217320`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e9e492edb2e5b66ceb0c4964496149501da2f133522f7d2829d213420169a008
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
